The paper studies derivative asset analysis in structural credit risk models where the asset value of the firm is not fully observable. It is shown that in order to determine the price dynamics of traded securities, one needs to solve a stochastic filtering problem for the asset value. We transform this problem to a filtering problem for a stopped diffusion process and apply results from the filtering literature to this problem. In this way, we obtain an stochastic partial differential equation characterization for the filter density. Moreover, we characterize the default intensity under incomplete information and determine the price dynamics of traded securities. Armed with these results, we study derivative assets in our setup: We explain how the model can be applied to the pricing of options on traded assets and we discuss dynamic hedging and model calibration. The paper closes with a small simulation study.
K E Y W O R D Sderivative asset analysis for corporate securities, incomplete information, stochastic filtering, structural credit risk models 84
The paper is concerned with counterparty credit risk management for credit default swaps in the presence of default contagion. In particular, we study the impact of default contagion on credit value adjustments such as the BCCVA (Bilateral Collateralized Credit Value Adjustment) of (Brigo et al. 2012) and on the performance of various collateralization strategies. We use the incomplete-information model of Frey and Schmidt (2012) as vehicle for our analysis. We find that taking contagion effects into account is important for the effectiveness of the strategy and we derive refined collateralization strategies to account for contagion effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.